Cargando…

Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system (CNS) that leads to progressive physical disability. Recent evidence has suggested that P2X7 receptor (P2X7R)-mediated purinergic signalling pathways play a role in MS-associated neuroinflammation, pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerini, Franca Rosa, Agliardi, Cristina, Bolognesi, Elisabetta, Zanzottera, Milena, Caputo, Domenico, Pasanisi, Maria Barbara, Rovaris, Marco, Clerici, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736555/
https://www.ncbi.nlm.nih.gov/pubmed/36499708
http://dx.doi.org/10.3390/ijms232315381
_version_ 1784847059299336192
author Guerini, Franca Rosa
Agliardi, Cristina
Bolognesi, Elisabetta
Zanzottera, Milena
Caputo, Domenico
Pasanisi, Maria Barbara
Rovaris, Marco
Clerici, Mario
author_facet Guerini, Franca Rosa
Agliardi, Cristina
Bolognesi, Elisabetta
Zanzottera, Milena
Caputo, Domenico
Pasanisi, Maria Barbara
Rovaris, Marco
Clerici, Mario
author_sort Guerini, Franca Rosa
collection PubMed
description Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system (CNS) that leads to progressive physical disability. Recent evidence has suggested that P2X7 receptor (P2X7R)-mediated purinergic signalling pathways play a role in MS-associated neuroinflammation, possibly contributing to disease pathogenesis. To evaluate possible associations between P2X7R polymorphisms and MS disease severity, we performed an association study of five non-synonymous SNPs coding variants of the P2X7R gene: rs1718119 Ala348Thr, rs2230911 Thr357Ser, rs2230912 Gln460Arg, rs3751143 Glu496Ala, and rs28360457 Arg307Gln, modulating P2X7R expression in 128 MS patients (relapsing remitting MS, RRMS: n = 94; secondary progressive, SPMS: n = 34). All patients were genotyped, and multiple sclerosis severity score (MSSS) was evaluated in every case; 189 healthy subjects were enrolled as well as controls. Results showed that P2X7R rs1718119(A) 348Thr and rs22390912(G) 464Arg, two SNPs of minor allele frequency (MAF) known to confer gain of function to the P2X7R protein, were associated with significantly higher MSSS in RRMS patients alone (SMRR (p < 0.001, p = 0.01, respectively)). Interestingly, two whole haplotypes resulted in having significant association with MSSS in these same patients. Thus: (1) the P2X7R-4 “ACGAG” haplotype, characterized by the co-presence of the rs1718119-rs2230912 AG MAF alleles, was associated with higher MSSS (Beta: 1.11 p = 0.04), and (2) the P2X7R-1 “GCAAG” complementary haplotype, which contains the rs1718119 and rs2230912 GA wild-type alleles, was more frequently carried by patients with lower MSSS and less severe disease (Beta: −1.54 p < 0.001). Although being preliminary and needing confirmation in an ampler cohort, these results suggest that 348Thr and 464Arg variants have a role as modulators of disease severity in RRMS patients.
format Online
Article
Text
id pubmed-9736555
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97365552022-12-11 Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis Guerini, Franca Rosa Agliardi, Cristina Bolognesi, Elisabetta Zanzottera, Milena Caputo, Domenico Pasanisi, Maria Barbara Rovaris, Marco Clerici, Mario Int J Mol Sci Communication Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system (CNS) that leads to progressive physical disability. Recent evidence has suggested that P2X7 receptor (P2X7R)-mediated purinergic signalling pathways play a role in MS-associated neuroinflammation, possibly contributing to disease pathogenesis. To evaluate possible associations between P2X7R polymorphisms and MS disease severity, we performed an association study of five non-synonymous SNPs coding variants of the P2X7R gene: rs1718119 Ala348Thr, rs2230911 Thr357Ser, rs2230912 Gln460Arg, rs3751143 Glu496Ala, and rs28360457 Arg307Gln, modulating P2X7R expression in 128 MS patients (relapsing remitting MS, RRMS: n = 94; secondary progressive, SPMS: n = 34). All patients were genotyped, and multiple sclerosis severity score (MSSS) was evaluated in every case; 189 healthy subjects were enrolled as well as controls. Results showed that P2X7R rs1718119(A) 348Thr and rs22390912(G) 464Arg, two SNPs of minor allele frequency (MAF) known to confer gain of function to the P2X7R protein, were associated with significantly higher MSSS in RRMS patients alone (SMRR (p < 0.001, p = 0.01, respectively)). Interestingly, two whole haplotypes resulted in having significant association with MSSS in these same patients. Thus: (1) the P2X7R-4 “ACGAG” haplotype, characterized by the co-presence of the rs1718119-rs2230912 AG MAF alleles, was associated with higher MSSS (Beta: 1.11 p = 0.04), and (2) the P2X7R-1 “GCAAG” complementary haplotype, which contains the rs1718119 and rs2230912 GA wild-type alleles, was more frequently carried by patients with lower MSSS and less severe disease (Beta: −1.54 p < 0.001). Although being preliminary and needing confirmation in an ampler cohort, these results suggest that 348Thr and 464Arg variants have a role as modulators of disease severity in RRMS patients. MDPI 2022-12-06 /pmc/articles/PMC9736555/ /pubmed/36499708 http://dx.doi.org/10.3390/ijms232315381 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Guerini, Franca Rosa
Agliardi, Cristina
Bolognesi, Elisabetta
Zanzottera, Milena
Caputo, Domenico
Pasanisi, Maria Barbara
Rovaris, Marco
Clerici, Mario
Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
title Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
title_full Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
title_fullStr Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
title_full_unstemmed Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
title_short Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
title_sort two single nucleotide polymorphisms in the purinergic receptor p2x7 gene are associated with disease severity in multiple sclerosis
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736555/
https://www.ncbi.nlm.nih.gov/pubmed/36499708
http://dx.doi.org/10.3390/ijms232315381
work_keys_str_mv AT guerinifrancarosa twosinglenucleotidepolymorphismsinthepurinergicreceptorp2x7geneareassociatedwithdiseaseseverityinmultiplesclerosis
AT agliardicristina twosinglenucleotidepolymorphismsinthepurinergicreceptorp2x7geneareassociatedwithdiseaseseverityinmultiplesclerosis
AT bolognesielisabetta twosinglenucleotidepolymorphismsinthepurinergicreceptorp2x7geneareassociatedwithdiseaseseverityinmultiplesclerosis
AT zanzotteramilena twosinglenucleotidepolymorphismsinthepurinergicreceptorp2x7geneareassociatedwithdiseaseseverityinmultiplesclerosis
AT caputodomenico twosinglenucleotidepolymorphismsinthepurinergicreceptorp2x7geneareassociatedwithdiseaseseverityinmultiplesclerosis
AT pasanisimariabarbara twosinglenucleotidepolymorphismsinthepurinergicreceptorp2x7geneareassociatedwithdiseaseseverityinmultiplesclerosis
AT rovarismarco twosinglenucleotidepolymorphismsinthepurinergicreceptorp2x7geneareassociatedwithdiseaseseverityinmultiplesclerosis
AT clericimario twosinglenucleotidepolymorphismsinthepurinergicreceptorp2x7geneareassociatedwithdiseaseseverityinmultiplesclerosis